Cargando…
Sublingual Administration of Sildenafil Oro-dispersible Film: New Profiles of Drug Tolerability and Pharmacokinetics for PDE5 Inhibitors
Objective: Type 5 phosphodiesterase inhibitors (PDE5i) are efficient drugs used for treatment of erectile dysfunction (ED); however, a large discontinuation rate due to major side effects is reported. The aim of this study was to evaluate the possible improvement of sildenafil (Sild) pharmacokinetic...
Autores principales: | De Toni, Luca, De Rocco Ponce, Maurizio, Franceschinis, Erica, Dall’Acqua, Stefano, Padrini, Roberto, Realdon, Nicola, Garolla, Andrea, Foresta, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808105/ https://www.ncbi.nlm.nih.gov/pubmed/29467656 http://dx.doi.org/10.3389/fphar.2018.00059 |
Ejemplares similares
-
Evaluation of Serum/Urine Genomic and Metabolomic Profiles to Improve the Adherence to Sildenafil Therapy in Patients with Erectile Dysfunction
por: Rocca, Maria Santa, et al.
Publicado: (2020) -
Comparative Evaluation of the Effects of Legacy and New Generation Perfluoralkyl Substances (PFAS) on Thyroid Cells In Vitro
por: De Toni, Luca, et al.
Publicado: (2022) -
Pharmacokinetics of a Novel Sildenafil Orodispersible Film Administered by the Supralingual and the Sublingual Route to Healthy Men
por: Loprete, Luca, et al.
Publicado: (2018) -
Membrane Cholesterol Inhibits Progesterone-Mediated Sperm Function through the Possible Involvement of ABHD2
por: De Toni, Luca, et al.
Publicado: (2023) -
Central serous chorioretinopathy treatment with a systemic PDE5 and PDE6 inhibitor (sildenafil)
por: Coleman, D. Jackson, et al.
Publicado: (2020)